The Affordable Care Act's mandate to increase Medicaid reimbursement to primary care providers has improved access to care for Medicaid enrollees, according to analysis of early evidence published in the New England Journal of Medicine.
The Affordable Care Act’s mandate to increase Medicaid reimbursement to primary care providers has improved access to care for Medicaid enrollees, according to analysis of early evidence published in the New England Journal of Medicine.
Daniel E. Polsky, PhD, of the University of Pennsylvania School of Medicine, and colleagues examined the association between the increase in Medicaid payments and appointment availability for Medicaid enrollees.
“Provider access is of particular concern for the Medicaid program, which is set to absorb the bulk of newly insured persons in many states, because Medicaid typically reimburses providers at much lower payment rates than those of Medicare and commercial insurers for the same services,” the authors wrote. “Lower payments have been cited as a critical barrier to access for primary care among Medicaid enrollees and are associated with lower provider availability for Medicaid patients.”
They estimated appointment availability in late 2012 to early 2013 and again in mid-2014 by using staff members to simulate patients seeking a new-patient appointment at primary care offices in Arkansas, Georgia, Illinois, Iowa, Massachusetts, Montana, New Jersey, Oregon, Pennsylvania, and Texas. Offices were selected at random and the simulated patients were assigned an insurance type at random.
Appointment availability for private-insurance callers stayed steady at 86% before and after the reimbursement increase, but appointment availability for Medicaid callers increased from 58.7% during the first set of calls to 66.4% during the second set of calls. New Jersey, Pennsylvania, Illinois, and Texas had the largest increases in Medicaid appointment availability and were also states with the largest increases in Medicaid reimbursements.
According to the researchers, there was strong evidence that providers who were participating in Medicaid in 2012 were more willing to schedule new-patient appointments with Medicaid beneficiaries in 2014.
The federal government has not extended funding for reimbursement increases and only 15 states plan to continue the reimbursement increases on their own.
“Our analysis shows that opting not to extend the enhanced payments may significantly decrease the availability of primary care appointments for Medicaid enrollees, particularly in states that had low Medicaid reimbursements before the increase,” the authors wrote.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More